Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects

Journal of Medical Virology

Volumn 69, Issue 3, 2003, Pages 350-356

  Gaud, Umesh ^a   Langer, Barbara ^b   Petropoulou, Theoni ^c   Thomas, Howard C ^a   Karayiannis, Peter ^a,d  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b Cryo Unit   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Agammaglobulinaemia; Common variable immunodeficiency disease; Hepatitis C virus; Hypervariable region 1; XLA

Indexed keywords

GLYCOPROTEIN;

ADULT; AGAMMAGLOBULINEMIA; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC HETEROGENEITY; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; MULTIGENE FAMILY; PROTEIN PROCESSING; VIRUS ENVELOPE; VIRUS GENOME; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; AMINO ACID SEQUENCE; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 0037358504     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10296     Document Type: Article

References (38)

1. Alter HJ. 1995. To C or not to C: these are the questions. Blood 85:1681-1695
2. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kuo G. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494-1500.
3. Ballow M. 2002. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol 109:581-591.
4. Booth JCL, Kumar U, Webster D, Monjardino J, Thomas HC. 1998. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 27:223-227.
5. Buckley RH. 1993. Primary immunodeficiency diseases. In: Paul WE, editor. Fundamental immunology. 3rd ed. New York: Raven Press. p 1353-1374.
6. Cerny A, Chisari FV. 1999. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30:595-601.
7. Conley ME. 1992. Bruton's agammaglobulinemia. In: Roitt IM, Delves PJ, editors. Encyclopedia of immunology. vol 1. London: Academic Press. p 260-262.
8. Cooper MD, Lawton AR. 1994. Primary immunedeficiency diseases. In: Isselbacher KJ, Braunwald E, Wilson JD, Joseph BM, Fauci AS, Kasper DL, editors. Harrison's principles of internal medicine. 13th ed. vol 2. London: McGraw-Hill. p 1559-1566.
9. Cramp ME, Carucci P, Rossol S, Chokshi S, Maertens G, Williams R, Naoumov NV. 1999. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 44:424-429.
10. + T cells in HCV-infected individuals responsive to IFN-α treatment. Virology 269:313-324.
11. Di Bisceglie AM, Hoofnagle JH. 1991. Therapy of chronic hepatitis C with α-interferon: the answer or more questions? Hepatology 13:601-603.
12. 4 T cells in HCV infection. Immunol Rev 174:90-97.
13. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushawar IK, Desai SM, Miller RH, Ogata N, Purcell RH. 1992a. Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140.
14. Farci P, London WT, Wong DC, Dawson GJ, Vallari DS, Engle R, Purcell RH. 1992b. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serological responses measured with first and second generation assays and relationship to HCV viraemia. J Infect Dis 165:1006-1011.
15. Ito T, Tahara SM, Lai MMC. 1998. The 3′-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol 72:8789-8796.
16. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K. 1993. Humoral immune response to hypervariable region 1 of the putative envelop glycoprotein (gp70) of hepatitis C virus. J Virol 67:3923-3930.
17. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
18. Kumar U, Monjardino J, Thomas HC. 1994. Hypervariable region of hepatitis C virus envelop glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 106:1072-1075.
19. Lai ME, Mazzoleni AP, Argiolu F, Vergilis SD, Balestrieri A, Purcell RH, Cao A, Farci P. 1994. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388-390.
20. Lamballerie XD, Charrel RN, Attoui H, Micco PD. 1997. Classification of hepatitis C virus variants in six major types based on analysis of the envelop 1 and non-structural 5B genome regions and complete polyprotein sequences. J Gen Virol 78:45-51.
21. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512.
22. Loriot MA, Bronowicki JP, Lagorce D, Lakehal F, Persico T, Barba G, Mergey M, Vons C, Franco D, Belghiti J, Giacca M, Housset C, Brechot C. 1999. Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology 29:1587-1595.
23. MacAllister J, Casino C, Davidson F, Power J, Lawlor E, Yap PL, Simmonds P, Smith DB. 1998. Long-term evolution of the hypervariable region of hepatitis C virus in a common source infected cohort. J Virol 72:4893-4905.
24. Major ME, Feinstone SM. 1997. The molecular virology of hepatitis C. Hepatology 25:1527-1538.
25. Manzin A, Solforosi L, Petrelli E, Macarri G, Tosone G, Piazza M, Clementi M. 1998. Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol 72:6271-6276.
26. Penin F, Combet C, Germanidid G, Frainais PO, Deleage G, Pawlotsky JM. 2001. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 75:5703-7410.
27. Quinti I, Pandolfi F, Paganelli R, el Salman D, Giovannetti A, Rosso R, Oliva A, Rainaldi L, Aiuti F. 1995. HCV infection in patients with primary defects of immunoglobulin production. Clin Exp Immunol 102:11-16.
28. Rehermann B. 2000. Interaction between hepatitis C virus and the immune system. Semin Liver Dis 20:127-141.
29. Rispeter K, Lu M, Behrens SE, Fumiko C, Yoshida T, Roggendorf M. 2000. Hepatitis C virus variability: sequence analysis of an isolate after 10 years of chronic infection. Virus Genes 21:179-188.
30. Rosen FS. 1993. The primary specific immunodeficiencies. In: Lachmann PJ, editor. Clinical aspects of immunology. 5th ed. Vol 2. Oxford: Blackwell Scientific. p 1271-1284.
31. Sakamoto N, Enomoto N, Kurosaki M, Marumo F, Sato C. 1994. Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection. J Med Virol 42:103-108.
32. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399.
33. Strimmer K, von Haeseler A. 1996. Quartet puzzling: a quartet maximum likelihood method for reconstructing tree topologies. Mol Biol Evol 13:964-969.
34. Tang S, Collier AJ, Elliott RM. 1999. Alteration to both the primary and predicted secondary structure of stem-loop IIIC of the hepatitis C virus 1b 5′ untranslated region (5′UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5′UTR sequence. J Virol 73:2359-2364.
35. Toyoda H, Fukuda Y, Koyama Y, Takamatsu J, Saito H, Hayakawa T. 1997. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 26:975-982.
36. Watson JP, Bevitt DJ, Spickett GP, Toms GL, Bassendine MF. 1996. Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immuno-competent patients. J Hepatol 25:599-607.
37. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo QL, Houghton M, Han JH. 1991. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842-848.
38. Weiner AJ, Greysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelop glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 89:3468-3472.